Skip to main content
Top
Published in: Strahlentherapie und Onkologie 5/2020

Open Access 01-05-2020 | Magnetic Resonance Imaging | Review Article

Magnetic resonance imaging for brain stereotactic radiotherapy

A review of requirements and pitfalls

Authors: Dr. med. Florian Putz, Veit Mengling, M.Sc., Rosalind Perrin, PhD, Siti Masitho, M.Sc., Dr. med. Thomas Weissmann, Dr. med. Johannes Rösch, Prof. Dr. med. Tobias Bäuerle, Prof. Dr. med. Rolf Janka, Prof. Dr. med. Alexander Cavallaro, Prof. Dr. med. Michael Uder, Prof. Dr. med. Patrick Amarteifio, Sylvain Doussin, PhD, Dr. med. Manuel Alexander Schmidt, Prof. Dr. med. Arndt Dörfler, PD Dr. med. Sabine Semrau, Dr. med. Sebastian Lettmaier, Prof. Dr. med. Rainer Fietkau, Prof. Dr. rer. nat. Christoph Bert

Published in: Strahlentherapie und Onkologie | Issue 5/2020

Login to get access

Abstract

Due to its superior soft tissue contrast, magnetic resonance imaging (MRI) is essential for many radiotherapy treatment indications. This is especially true for treatment planning in intracranial tumors, where MRI has a long-standing history for target delineation in clinical practice. Despite its routine use, care has to be taken when selecting and acquiring MRI studies for the purpose of radiotherapy treatment planning. Requirements on MRI are particularly demanding for intracranial stereotactic radiotherapy, where accurate imaging has a critical role in treatment success. However, MR images acquired for routine radiological assessment are frequently unsuitable for high-precision stereotactic radiotherapy as the requirements for imaging are significantly different for radiotherapy planning and diagnostic radiology. To assure that optimal imaging is used for treatment planning, the radiation oncologist needs proper knowledge of the most important requirements concerning the use of MRI in brain stereotactic radiotherapy. In the present review, we summarize and discuss the most relevant issues when using MR images for target volume delineation in intracranial stereotactic radiotherapy.
Literature
5.
go back to reference Seibert TM, White NS, Kim GY, Moiseenko V, McDonald CR, Farid N, Bartsch H, Kuperman J, Karunamuni R, Marshall D, Holland D, Sanghvi P, Simpson DR, Mundt AJ, Dale AM, Hattangadi-Gluth JA (2016) Distortion inherent to magnetic resonance imaging can lead to geometric miss in radiosurgery planning. Pract Radiat Oncol 6(6):e319–e328. https://doi.org/10.1016/j.prro.2016.05.008 CrossRefPubMedPubMedCentral Seibert TM, White NS, Kim GY, Moiseenko V, McDonald CR, Farid N, Bartsch H, Kuperman J, Karunamuni R, Marshall D, Holland D, Sanghvi P, Simpson DR, Mundt AJ, Dale AM, Hattangadi-Gluth JA (2016) Distortion inherent to magnetic resonance imaging can lead to geometric miss in radiosurgery planning. Pract Radiat Oncol 6(6):e319–e328. https://​doi.​org/​10.​1016/​j.​prro.​2016.​05.​008 CrossRefPubMedPubMedCentral
8.
go back to reference Schmitt D, Blanck O, Gauer T, Fix M, Brunner T, Fleckenstein J, Loutfi-Krauss B, Manser P, Werner R, Wilhelm M, Baus W, Moustakis C (2020) Technological quality requirements for stereotactic radiotherapy. Expert review group consensus from the DGMP working group for physics and technology in stereotactic radiotherapy. Strahlenther Onkol : (Under Parallel Review) Schmitt D, Blanck O, Gauer T, Fix M, Brunner T, Fleckenstein J, Loutfi-Krauss B, Manser P, Werner R, Wilhelm M, Baus W, Moustakis C (2020) Technological quality requirements for stereotactic radiotherapy. Expert review group consensus from the DGMP working group for physics and technology in stereotactic radiotherapy. Strahlenther Onkol : (Under Parallel Review)
9.
10.
go back to reference Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90–05. Int J Radiat Oncol Biol Phys 47(2):291–298CrossRef Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90–05. Int J Radiat Oncol Biol Phys 47(2):291–298CrossRef
14.
go back to reference Nardone V, Nanni S, Pastina P, Vinciguerra C, Cerase A, Correale P, Guida C, Giordano A, Tini P, Reginelli A, Cappabianca S, Pirtoli L (2019) Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases. Strahlenther Onkol 195(8):734–744. https://doi.org/10.1007/s00066-019-01475-0 CrossRefPubMed Nardone V, Nanni S, Pastina P, Vinciguerra C, Cerase A, Correale P, Guida C, Giordano A, Tini P, Reginelli A, Cappabianca S, Pirtoli L (2019) Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases. Strahlenther Onkol 195(8):734–744. https://​doi.​org/​10.​1007/​s00066-019-01475-0 CrossRefPubMed
26.
39.
48.
go back to reference Heid O (1996) Noniterative localized in vivo shimming in B15s. Proc Int Soc Magn Res Med 363 Heid O (1996) Noniterative localized in vivo shimming in B15s. Proc Int Soc Magn Res Med 363
56.
go back to reference Danieli L, Riccitelli GC, Distefano D, Prodi E, Ventura E, Cianfoni A, Kaelin-Lang A, Reinert M, Pravata E (2019) Brain tumor-enhancement visualization and morphometric assessment: a comparison of MPRAGE, SPACE, and VIBE MRI techniques. AJNR Am J Neuroradiol 40(7):1140–1148. https://doi.org/10.3174/ajnr.A6096 CrossRefPubMed Danieli L, Riccitelli GC, Distefano D, Prodi E, Ventura E, Cianfoni A, Kaelin-Lang A, Reinert M, Pravata E (2019) Brain tumor-enhancement visualization and morphometric assessment: a comparison of MPRAGE, SPACE, and VIBE MRI techniques. AJNR Am J Neuroradiol 40(7):1140–1148. https://​doi.​org/​10.​3174/​ajnr.​A6096 CrossRefPubMed
57.
go back to reference Ellingson BM, Bendszus M, Boxerman J, Barboriak D, Erickson BJ, Smits M, Nelson SJ, Gerstner E, Alexander B, Goldmacher G, Wick W, Vogelbaum M, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Pope WB, Yang D, Chung C, Knopp MV, Cha S, van den Bent MJ, Chang S, Yung WK, Cloughesy TF, Wen PY, Gilbert MR (2015) Consensus recommendations for a standardized brain tumor imaging protocol in clinical trials. Neuro-Oncology 17(9):1188–1198. https://doi.org/10.1093/neuonc/nov095 CrossRefPubMedPubMedCentral Ellingson BM, Bendszus M, Boxerman J, Barboriak D, Erickson BJ, Smits M, Nelson SJ, Gerstner E, Alexander B, Goldmacher G, Wick W, Vogelbaum M, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Pope WB, Yang D, Chung C, Knopp MV, Cha S, van den Bent MJ, Chang S, Yung WK, Cloughesy TF, Wen PY, Gilbert MR (2015) Consensus recommendations for a standardized brain tumor imaging protocol in clinical trials. Neuro-Oncology 17(9):1188–1198. https://​doi.​org/​10.​1093/​neuonc/​nov095 CrossRefPubMedPubMedCentral
58.
go back to reference Chappell PM, Pelc NJ, Foo TK, Glover GH, Haros SP, Enzmann DR (1994) Comparison of lesion enhancement on spin-echo and gradient-echo images. AJNR Am J Neuroradiol 15(1):37–44PubMed Chappell PM, Pelc NJ, Foo TK, Glover GH, Haros SP, Enzmann DR (1994) Comparison of lesion enhancement on spin-echo and gradient-echo images. AJNR Am J Neuroradiol 15(1):37–44PubMed
59.
go back to reference Reichert M, Morelli JN, Runge VM, Tao A, von Ritschl R, von Ritschl A, Padua A, Dix JE, Marra MJ, Schoenberg SO, Attenberger UI (2013) Contrast-enhanced 3‑dimensional SPACE versus MP-RAGE for the detection of brain metastases: considerations with a 32-channel head coil. Invest Radiol 48(1):55–60. https://doi.org/10.1097/RLI.0b013e318277b1aa CrossRefPubMed Reichert M, Morelli JN, Runge VM, Tao A, von Ritschl R, von Ritschl A, Padua A, Dix JE, Marra MJ, Schoenberg SO, Attenberger UI (2013) Contrast-enhanced 3‑dimensional SPACE versus MP-RAGE for the detection of brain metastases: considerations with a 32-channel head coil. Invest Radiol 48(1):55–60. https://​doi.​org/​10.​1097/​RLI.​0b013e318277b1aa​ CrossRefPubMed
60.
go back to reference Komada T, Naganawa S, Ogawa H, Matsushima M, Kubota S, Kawai H, Fukatsu H, Ikeda M, Kawamura M, Sakurai Y, Maruyama K (2008) Contrast-enhanced MR imaging of metastatic brain tumor at 3 tesla: utility of T(1)-weighted SPACE compared with 2D spin echo and 3D gradient echo sequence. Magn Reson Med Sci 7(1):13–21. https://doi.org/10.2463/mrms.7.13 CrossRefPubMed Komada T, Naganawa S, Ogawa H, Matsushima M, Kubota S, Kawai H, Fukatsu H, Ikeda M, Kawamura M, Sakurai Y, Maruyama K (2008) Contrast-enhanced MR imaging of metastatic brain tumor at 3 tesla: utility of T(1)-weighted SPACE compared with 2D spin echo and 3D gradient echo sequence. Magn Reson Med Sci 7(1):13–21. https://​doi.​org/​10.​2463/​mrms.​7.​13 CrossRefPubMed
62.
go back to reference Yuh WT, Tali ET, Nguyen HD, Simonson TM, Mayr NA, Fisher DJ (1995) The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. AJNR Am J Neuroradiol 16(2):373–380PubMed Yuh WT, Tali ET, Nguyen HD, Simonson TM, Mayr NA, Fisher DJ (1995) The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. AJNR Am J Neuroradiol 16(2):373–380PubMed
63.
go back to reference Baleriaux D, Colosimo C, Ruscalleda J, Korves M, Schneider G, Bohndorf K, Bongartz G, van Buchem MA, Reiser M, Sartor K, Bourne MW, Parizel PM, Cherryman GR, Salerio I, La Noce A, Pirovano G, Kirchin MA, Spinazzi A (2002) Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine. Neuroradiology 44(3):191–203. https://doi.org/10.1007/s002340100636 CrossRefPubMed Baleriaux D, Colosimo C, Ruscalleda J, Korves M, Schneider G, Bohndorf K, Bongartz G, van Buchem MA, Reiser M, Sartor K, Bourne MW, Parizel PM, Cherryman GR, Salerio I, La Noce A, Pirovano G, Kirchin MA, Spinazzi A (2002) Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine. Neuroradiology 44(3):191–203. https://​doi.​org/​10.​1007/​s002340100636 CrossRefPubMed
Metadata
Title
Magnetic resonance imaging for brain stereotactic radiotherapy
A review of requirements and pitfalls
Authors
Dr. med. Florian Putz
Veit Mengling, M.Sc.
Rosalind Perrin, PhD
Siti Masitho, M.Sc.
Dr. med. Thomas Weissmann
Dr. med. Johannes Rösch
Prof. Dr. med. Tobias Bäuerle
Prof. Dr. med. Rolf Janka
Prof. Dr. med. Alexander Cavallaro
Prof. Dr. med. Michael Uder
Prof. Dr. med. Patrick Amarteifio
Sylvain Doussin, PhD
Dr. med. Manuel Alexander Schmidt
Prof. Dr. med. Arndt Dörfler
PD Dr. med. Sabine Semrau
Dr. med. Sebastian Lettmaier
Prof. Dr. med. Rainer Fietkau
Prof. Dr. rer. nat. Christoph Bert
Publication date
01-05-2020
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 5/2020
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-020-01604-0

Other articles of this Issue 5/2020

Strahlentherapie und Onkologie 5/2020 Go to the issue